GAMMA Investing LLC Has $56,000 Stake in Sotera Health (NASDAQ:SHC)

GAMMA Investing LLC grew its stake in shares of Sotera Health (NASDAQ:SHC) by 37.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,109 shares of the company’s stock after purchasing an additional 1,121 shares during the quarter. GAMMA Investing LLC’s holdings in Sotera Health were worth $56,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Darsana Capital Partners LP raised its holdings in Sotera Health by 716.9% in the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock valued at $334,167,000 after acquiring an additional 17,560,636 shares during the period. Sessa Capital IM L.P. increased its position in Sotera Health by 46.5% during the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after buying an additional 2,000,000 shares during the period. State Street Corp raised its stake in Sotera Health by 18.5% in the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after purchasing an additional 644,236 shares in the last quarter. AQR Capital Management LLC grew its position in Sotera Health by 3,198.2% during the second quarter. AQR Capital Management LLC now owns 511,580 shares of the company’s stock worth $6,072,000 after buying an additional 496,069 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Sotera Health by 19.4% in the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after purchasing an additional 447,186 shares during the period. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Stock Down 2.1 %

SHC opened at $13.11 on Monday. The company’s 50-day moving average price is $13.73 and its two-hundred day moving average price is $14.42. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The stock has a market cap of $3.71 billion, a price-to-earnings ratio of 52.44 and a beta of 1.92. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. During the same period in the previous year, the firm earned $0.18 EPS. The company’s revenue was up 8.5% compared to the same quarter last year. As a group, equities analysts expect that Sotera Health will post 0.61 earnings per share for the current year.

Wall Street Analyst Weigh In

SHC has been the topic of a number of research analyst reports. Citigroup raised their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Finally, The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective for the company. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $16.08.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.